- All Drug Categories
- Home
- Anti-cancer Drugs
- Healthcare Products
- Medical Information
- Statement
Gilteritinib has significant therapeutic effects on FLT3 mutation positive AML patients, but the discontinuation process needs to be standardiz...
Gilteritinib is an FLT3 tyrosine kinase inhibitor primarily used to treat relapsed/refractory acute myeloid leukemia (AML) with FLT3 mutation p...
Blujepa, as an antibacterial drug, has specific contraindications, dietary restrictions, and medication constraints when used. The following pr...
The therapeutic effect of Blujepa needs to be evaluated based on specific indications, and its discontinuation process should follow a gradual ...
The side effects of Acoramidis mainly include reactions in the cardiovascular and digestive systems, and corresponding relief measures should b...
Acoramidis is a medication used to treat specific cardiovascular diseases, and its indications and medication precautions must strictly follow ...
Defibrotide is mainly used to treat hepatic vein occlusion (VOD) after hematopoietic stem cell transplantation, and its use requires special at...
The side effects of Defibrotide mainly include bleeding tendency, gastrointestinal reactions, and allergic reactions, most of which can be al...
The therapeutic effect of Pimitesib needs to be evaluated based on individual conditions, and discontinuation should strictly follow medical gu...
The usage and dosage of Pimitesib should strictly follow medical advice, and medication for special populations should be adjusted according to...
